16 mg: Betahistine Dihydrochloride is indicated for the treatment of Ménière's syndrome or vestibular vertigo.
24 mg: Betahistine Dihydrochloride is used to reduce the symptoms of vertigo, tinnitus, and hearing loss associated with Ménière's disease.
Other Services
Country
Support
Account
Sign Out